ID: ALA4469909

Max Phase: Preclinical

Molecular Formula: C22H31NO5

Molecular Weight: 389.49

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1CCC2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1CCOc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C22H31NO5/c1-15-4-9-19-21(2,12-10-20(25)22(19,3)14-24)18(15)11-13-28-17-7-5-16(6-8-17)23(26)27/h5-8,18-20,24-25H,1,4,9-14H2,2-3H3/t18-,19?,20-,21+,22+/m1/s1

Standard InChI Key:  ZEKSDKMIWAFQQH-FAEIBLRNSA-N

Associated Targets(non-human)

Transcription factor p65 175 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NF-kappa-B inhibitor alpha 54 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.49Molecular Weight (Monoisotopic): 389.2202AlogP: 4.11#Rotatable Bonds: 6
Polar Surface Area: 92.83Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.55CX LogD: 3.55
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: 1.36

References

1. Wang W, Wu Y, Chen X, Zhang P, Li H, Chen L..  (2019)  Synthesis of new ent-labdane diterpene derivatives from andrographolide and evaluation of their anti-inflammatory activities.,  162  [PMID:30419492] [10.1016/j.ejmech.2018.11.002]

Source